Indeed, brain delivery of exogenous neurotrophic factors, such as the neurotrophin nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF), can reduce infarct volumes by 60–90% with near total restoration of behavioral function in experimental stroke models. This evidence concerns the gene NGF and stroke disorder.